Leukemia Inhibitory Factor - HIV-1 inhibitorAlternative Names: HIV-1 inhibitor - Leukemia Inhibitory Factor; LIF - HIV-1 inhibitor
Latest Information Update: 04 May 2007
At a glance
- Originator Childrens Memorial Hospital (Chicago)
- Developer Childrens Memorial Hospital (Chicago); Invirion Corporation
- Class Proteins
- Mechanism of Action HIV replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections